Featured
Read our handpicked blogs, curated for you.
|
The Growing Risk of AI Vendor Lock-InEnterprise AI adoption is accelerating at an extraordinary pace. Organizations are…
|
The Silent Crisis in Enterprise AIEnterprises are rapidly deploying AI copilots, autonomous agents, retrieval systems,…
|
The Rising Risk in Modern Digital WorkplacesEmployees share files across Teams, SharePoint, email, and external…
Recent releases
|
AI in Clinical Trials Market: Data to Decisions
The AI in clinical trials market is entering a crucial phase of growth. Globally, it’s projected to jump from USD 1.35 billion in 2024 to USD 2.74 billion by 2030, growing at a CAGR of 12.4%. For…
|
Proving Marketing ROI to the Board with Engagement Data
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If your team is still defending budgets with vanity metrics, you lose ground.…
|
Veeva vs Modular CMS: Which Is Better for Pharma Content Approvals?
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the content approval cycle drags on for weeks, sometimes months. Every delay costs…
|
HCP Engagement Analytics & Metrics Every Pharma CMO Must Track
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to know not just if doctors were contacted, but whether those interactions drove…
